Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results

Go back to Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results
Myriad Genetics, Inc. (NASDAQ: MYGN) Delayed: 3.19 -0.04 (1.24%)
Previous Close $3.23    52 Week High $45.34 
Open $3.19    52 Week Low $15.92 
Day High $3.20    P/E 1.37 
Day Low $3.15    EPS $2.33 
Volume 805,865